Publication | Closed Access

LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling

Tumor BiologyRadiation OncologyLncrna Pca3MedicineMir-132-3 P/srebp1Cancer BiologyMicrorna DetectionTumor SuppressorMetabolic SignalingCancer MetabolismCell BiologyCancer ResearchLipid Synthesis